Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04161768
PHASE3
Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Sponsor: Tanta University
View on ClinicalTrials.gov
Summary
Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Official title: Comparative Study of Norfloxacin Versus Norfloxacin With Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2018-12-01
Completion Date
2028-12-01
Last Updated
2019-11-13
Healthy Volunteers
No
Conditions
Interventions
DRUG
Norfloxacin
Norfloxacin 400 mg daily
DRUG
Itopride
Itopride 50 mg three times daily
Locations (1)
Sherief Abd-Elsalam
Tanta, Egypt